Hanash, Samir M
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #39,364
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Internal Medicine
NIH Funding · FY2022
Linked Award Amount
$185.6K
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#39,364
By linked amount among FY2022 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Hanash, Samir M as a PI. Multi-PI records show the full award amount for context.
- 5R21CA255581-02R21Contact PIProstate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapyUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$185.6Kaward amount
Award organization
Organizations that administered FY2022 awards listing Hanash, Samir M as a PI.
FY2022 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUT MD Anderson Cancer Center
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001$2M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #289
- 2001Entered Top 25% NationallyRanked #289
- 2001Entered Top 10% NationallyRanked #289
- 2001Entered Top 5% NationallyRanked #289
- 2002$5M Cumulative Funding
- 2004$10M Cumulative Funding